{"id":7291,"date":"2024-04-26T22:31:13","date_gmt":"2024-04-27T04:31:13","guid":{"rendered":"https:\/\/cjcadvisorynetwork.com\/?p=7291"},"modified":"2024-04-26T22:53:58","modified_gmt":"2024-04-27T04:53:58","slug":"japan-designates-cannabis-derived-cbd-as-orphan-drug-a-national-first","status":"publish","type":"post","link":"https:\/\/cjcadvisorynetwork.com\/ja\/japan-designates-cannabis-derived-cbd-as-orphan-drug-a-national-first","title":{"rendered":"<strong>Japan Designates Cannabis-Derived CBD as Orphan Drug, a National First<\/strong>"},"content":{"rendered":"<div data-elementor-type=\"wp-post\" data-elementor-id=\"7291\" class=\"elementor elementor-7291\" data-elementor-post-type=\"post\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-3e1f02a elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"3e1f02a\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-61e7cf3\" data-id=\"61e7cf3\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-92a18af elementor-widget elementor-widget-text-editor\" data-id=\"92a18af\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>On April 26, Japan&#8217;s Ministry of Health, Labor, and Welfare\u2019s special committee greenlit cannabidiol (CBD) as an Orphan Drug, marking the first-ever approval of a cannabis-derived antiepileptic drug in the country. Marketed abroad under the brand name Epidiolex, CBD has now set a historic precedent in Japan\u2019s pharmaceutical landscape. This significant development was reported by&nbsp;<a href=\"https:\/\/www.nikkei.com\/article\/DGXZQOUA263TH0W4A420C2000000\/\" target=\"_blank\">NIKKEI<\/a>.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-366ad17 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"366ad17\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-3c58fa2\" data-id=\"3c58fa2\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-c121c4a elementor-widget elementor-widget-text-editor\" data-id=\"c121c4a\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\tOrphan drugs target conditions that affect a small patient population and lack established treatment protocols. With this designation, CBD will now receive expedited review from the Pharmaceuticals and Medical Devices Agency (PMDA), accelerating its path to market.\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-4e8fbe2 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"4e8fbe2\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-2c03bb1\" data-id=\"2c03bb1\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-3ac5dc7 elementor-widget elementor-widget-text-editor\" data-id=\"3ac5dc7\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\tIn Japan, strict regulations require extensive clinical trials, which are currently shaping the future of CBD medications. The amendments of Cannabis Control Law in 2023 has facilitated these developments, and post-approval, CBD is expected to be used medically, fulfilling significant demand from Japanese healthcare professionals.\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-f336cfd elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"f336cfd\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-8c84eab\" data-id=\"8c84eab\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"<p>On April 26, Japan&#8217;s Ministry of Health, Labor, and Welfare\u2019s special committee greenlit cannabidiol (CBD) as an Orphan Drug, marking the first-ever approval of a cannabis-derived antiepileptic drug in the country. Marketed abroad under the brand name Epidiolex, CBD has now set a historic precedent in Japan\u2019s pharmaceutical landscape. This significant development was reported by&nbsp;NIKKEI. Orphan drugs target conditions that affect a small patient population and lack established treatment protocols. With this designation, CBD will now receive expedited review from the Pharmaceuticals and Medical Devices Agency (PMDA), accelerating its path to market.In Japan, strict regulations require extensive clinical trials, which are currently shaping the future of CBD medications. The amendments [&hellip;]<\/p>","protected":false},"author":5,"featured_media":7302,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[19],"tags":[],"class_list":["post-7291","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-cannabis-news"],"aioseo_notices":[],"jetpack_featured_media_url":"https:\/\/i0.wp.com\/cjcadvisorynetwork.com\/wp-content\/uploads\/2024\/04\/%E3%83%98%E3%83%B3%E3%83%97%E3%81%AE%E4%BD%BF%E7%94%A8%E7%94%A8%E9%80%94-2.jpg?fit=1920%2C1080&ssl=1","jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/paU7fn-1TB","jetpack-related-posts":[],"_links":{"self":[{"href":"https:\/\/cjcadvisorynetwork.com\/ja\/wp-json\/wp\/v2\/posts\/7291","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cjcadvisorynetwork.com\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cjcadvisorynetwork.com\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cjcadvisorynetwork.com\/ja\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/cjcadvisorynetwork.com\/ja\/wp-json\/wp\/v2\/comments?post=7291"}],"version-history":[{"count":10,"href":"https:\/\/cjcadvisorynetwork.com\/ja\/wp-json\/wp\/v2\/posts\/7291\/revisions"}],"predecessor-version":[{"id":7304,"href":"https:\/\/cjcadvisorynetwork.com\/ja\/wp-json\/wp\/v2\/posts\/7291\/revisions\/7304"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cjcadvisorynetwork.com\/ja\/wp-json\/wp\/v2\/media\/7302"}],"wp:attachment":[{"href":"https:\/\/cjcadvisorynetwork.com\/ja\/wp-json\/wp\/v2\/media?parent=7291"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cjcadvisorynetwork.com\/ja\/wp-json\/wp\/v2\/categories?post=7291"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cjcadvisorynetwork.com\/ja\/wp-json\/wp\/v2\/tags?post=7291"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}